药物 | 研究阶段 | 乳腺癌 |
Exemestane + everolimus | Phase III (randomized trial) | Advanced breast cancer (hormone-receptor-positive) [24] |
Temsirolimus | Phase II | Metastatic breast cancer [25] |
Tamoxifen + everolimus | Phase II (randomized trial) | Metastatic breast cancer [26] |
Plustrastuzumab + vinorelbine + everolimus | Phase III | HER2-positivebreast cancer [27] |
Trastuzumab + ridaforolimus | Phase IIb | Trastuzumab-refractory metastatic breast cancer (human epidermal growth factor receptor 2-positive) [28] |
Paclitaxel + trastuzumab + everolimus | Phase II | Advanced breast cancer (HER-2 positive) [29] |